Manipal Hospitals
Wilms tumor treatment cost in India typically involves an initial consultation with an oncologist costing AUD $17 – AUD $58. Surgical removal of nephroblastoma runs Price on request , while complex treatment including combined therapies ranges from Price on request to Price on request . Total expenses depend on the cancer stage and hospital location. Australians often save 60–80% compared to local private healthcare costs. Top treatment hubs include Bengaluru, Delhi, and Mumbai.
Typical Wilms Tumor (Nephroblastoma) Treatment Costs in India
Bookimed Expert Insight: For complex paediatric cases, multidisciplinary centres like HCG Manavata Cancer Centre offer specialized paediatric oncology teams. Families seeking advanced technology should consider Fortis Gurgaon. It was ranked as the second most technically advanced hospital worldwide. Specialists like Dr. Gaurav Kharya bring extensive experience in paediatric blood disorders. This ensures treatment protocols follow international standards. JCI-accredited facilities like BLK Super Speciality Hospital use European-standard diagnostic equipment for precise staging.
| India | Thailand | Turkey | |
| Radiation therapy for colorectal cancer | from AUD $4,623 | from AUD $7,946 | from AUD $10,113 |
| Chemotherapy for breast cancer | from AUD $5,056 | from AUD $4,334 | from AUD $1,734 |
No hidden fees – just official clinic prices. Pay at the clinic for Wilms tumor (Nephroblastoma) treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Wilms tumor (Nephroblastoma) treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Wilms tumor (Nephroblastoma) treatment journey.
Dr Shruti Kate trained in paediatric tumours at the Tata Memorial Hospital, one of the most prominent cancer research centres in South Asia.
Dr Gaurav Kharya is a specialist in paediatric haematology and oncology who leads the blood and marrow transplant team at Artemis Hospitals.
Wilms tumour treatment in India achieves high overall survival rates between 75% and 91.5%. Localised cases diagnosed early reach 85% to 90% survival. Advanced tumours respond well to modern risk-adapted protocols. Indian specialists deliver outcomes comparable to developed nations through integrated surgical and haematological care.
Bookimed Expert Insight: Indian oncology centres often lead in volume-based expertise. HCG Manavata Cancer Centre serves over 75,000 patients annually. This high patient turnover means paediatric teams handle rare, complex presentations more often than lower-volume international centres. This experience improves surgical precision and outcome predictability for nephroblastoma cases.
Patient Consensus: Parents find India a strong option because many top hospitals use the same risk-adapted care used in Australia. They note that survival depends heavily on quick diagnosis and tailored chemotherapy. Major Indian private hospitals provide this with minimal waiting times.
Treatment for Wilms tumour in India uses a multimodal approach combining surgery, chemotherapy, and radiotherapy. Many centres follow the SIOP protocol, using preoperative chemotherapy to shrink tumours before surgical removal. This strategy helps reduce complications during surgery and manage large tumours more effectively.
Bookimed Expert Insight: Indian tertiary centres like HCG Manavata and Indraprastha Apollo offer a depth of technology rarely found in single locations. While many hospitals provide standard care, these facilities integrate PET-MR imaging with specialised paediatric units. This combination allows more precise staging of childhood tumours. This is vital for deciding whether to use neoadjuvant chemotherapy or proceed straight to surgery.
Patient Consensus: Families note that Indian centres handle complex bilateral cases well, sometimes using kidney auto-transplants. They also emphasise monitoring for chemotherapy-induced neuropathy during and after treatment in India.
A kidney is not always removed for Wilms tumour treatment in India. Total nephrectomy is the standard for one-sided tumours. However, specialists use kidney-sparing surgery for small or bilateral cases. Modern Indian protocols often include chemotherapy to shrink tumours before surgery. This helps preserve as much healthy tissue as possible.
Bookimed Expert Insight: Indian cancer centres like HCG Manavata and BLK Super Speciality treat thousands of patients annually. Large-scale centres often have dedicated paediatric oncology units. These units offer diagnostics like PET-CT and robotic systems. This high patient volume gives surgeons extensive experience in complex kidney-sparing procedures.
Patient Consensus: Parents note that auto-transplant techniques in Delhi can save kidney tissue in bilateral cases. It is important to confirm early whether the disease is unilateral or bilateral.
Indian oncologists typically use Vincristine and Actinomycin D as primary chemotherapy drugs for Wilms tumour. Advanced cases often include Doxorubicin or Cyclophosphamide. Most centres follow international SIOP protocols. These often start with chemotherapy before surgery to shrink the tumour safely.
Bookimed Expert Insight: Indian hospitals like BLK Super Speciality and HCG Manavata handle massive oncology volumes. Manavata performs over 65,000 surgeries. This high patient load means oncologists have extensive experience managing drug toxicities in children. Australian families should note that JCI-accredited facilities in Delhi and Bengaluru provide the same drug protocols used in major Western centres. They offer these at a lower cost.
Patient Consensus: Patients highlight that standard drug protocols often include antibiotics like Vancomycin. These help manage infection risks during treatment. Families in India typically stress confirming the clinic follows SIOP or NWTSG guidelines. They recommend doing this before starting chemotherapy.
India provides high-quality paediatric oncology care for Wilms tumour. Survival rates exceed 90% for localised cases. Accredited centres such as BLK Super Speciality Hospital and Indraprastha Apollo Hospital follow international SIOP and COG protocols. Treatment is significantly more affordable than in Australia or the United States.
Bookimed Expert Insight: Indian oncology centres handle massive patient volumes, with Manipal Hospitals serving 2,000,000 patients annually. This high turnover means surgeons like Dr Shruti Kate at HCG Manavata Cancer Centre have exceptional practical experience. They often see more rare paediatric cases in a month. That is more than many Western specialists see in a year.
Patient Consensus: Parents value the risk-adapted approach. Doctors tailor treatment intensity to the child's specific tumour biology. Patients note that India's surgical teams are highly skilled in managing complex bilateral cases. They also focus on long-term kidney health.
Top Indian hospitals for paediatric nephroblastoma treatment include Fortis Memorial Research Institute (FMRI) in Gurgaon, HCG Manavata Cancer Centre in Nashik, and BLK Super Speciality Hospital. These JCI and NABH-accredited facilities provide multidisciplinary care involving specialist paediatric oncologists and surgeons.
Bookimed Expert Insight: Indian oncology hubs often share high-level expertise through their senior staff. Dr Shruti Kate at HCG Manavata previously served at Tata Memorial Hospital, India's premier cancer centre. This means patients in regional centres like Nashik receive the same specialised treatment protocols as those in major metropolitan hospitals.
Patient Consensus: Families note it is vital to confirm the hospital has a dedicated paediatric unit before arrival. Patients in India suggest verifying that teams include both a paediatric surgeon and an oncologist for nephroblastoma cases.